Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Georgia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Georgia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Georgia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Hemophilia Of Georgia (NPI 1699778563)

Field	Value
Entity Type	Organization
Organization	Hemophilia Of Georgia
Address	8607 Roberts Dr Ste 150
City	Sandy Springs
State	GA
ZIP	30350
Taxonomy	Specialty Pharmacy
NPI Enumerated	May 24, 2005

Payer Source	Total Paid
Medicare	$6.1M
Medicaid	$0

Key Findings

All of the provider's reported Medicare revenue is concentrated in a single specialty biologic billing line: J7170 (Injection, emicizumab-kxwh, 0.5 mg). The file shows 152.9K claims for this code, a $40 avg paid/claim, and $6.1M revenue, which together define the firm's operative service line as specialty hemophilia medication dispensing/administration rather than broad outpatient procedural care.

Revenue concentration is extreme: the precomputed top-3 codes account for 100.0% of this provider's total Medicare revenue, and the available detail shows that concentration is effectively carried by J7170 alone. That degree of single-therapy dependence creates material business risk if reimbursement, utilization, or supply dynamics for emicizumab change.

Payer mix is effectively single-payer Medicare: total Medicare revenue is $6.1M while there is no Medicaid billing on file. The absence of Medicaid billing suggests the provider either does not participate in Medicaid programs or has not billed Medicaid, which narrows revenue diversification and could limit access to lower-income patient populations.

Competitive standing on the reported code is modest at the national level: J7170 for this provider ranks #4 of 6 providers nationally (40th percentile; typical, unremarkable volume for this code). This rank indicates the provider is not a dominant national supplier of emicizumab but is a measurable, middle-tier participant among the small set of reporting entities.

The per-claim economics point to unit-based billing behavior: a $40 avg paid/claim for J7170 (0.5 mg unit) alongside 152.9K claims implies many small-unit billings rather than a small number of high-dollar claims. This pattern is consistent with granular, unit-level billing for a high-cost biologic and has implications for utilization management, inventory handling, and pharmacy reimbursement reconciliation.

Statistical standing is not extreme: the data label for J7170 explicitly characterizes the provider's volume as "typical, unremarkable," and the national percentile position (40th) aligns with that description. There is no indication in the supplied metrics that this provider is a statistical outlier on Medicare for the reported code.

The provider has a long operational tenure under its NPI, enumerated 2005-05-24 (~21 years ago), which supports the interpretation of an established specialty pharmacy operation rather than a recently formed billing entity. Longevity may afford advantages in vendor contracts, payer relationships, and supply-chain experience for hemophilia therapies.

The combination of a single-code revenue base, absence of Medicaid activity, and a middle-tier national rank signals limited scale and regional focus: the entity generates meaningful Medicare revenue ($6.1M) but lacks diversification across payers and therapeutic codes. For payers and competitors, this profile suggests the provider is a specialized, established supplier of emicizumab with concentrated exposure rather than a broad, multi-payer specialty pharmacy network.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

1 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J7170	Injection, emicizumab-kxwh, 0.5 mg	152,910	$40	$6.1M

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 1 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Georgia Distribution

Hemophilia Of Georgia — 0 of 1 code billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Georgia

Full comparison — all codes billed, vs. state median

1 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J7170	1	10	152,910	$40	$6.1M

Nearby Providers

Other providers in the same ZIP code as Hemophilia Of Georgia, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ispm Labs, LLC	GA	Clinical Medical Laboratory	$0	$8M
Carepoint Lab, LLC	GA	Clinical Medical Laboratory	$274.7K	$3M
Psychiatric Consultants Of Atlanta	GA	Adolescent and Children Mental Health Clinic/Center	$0	$1.8M
Shepard Health LLC	GA	Clinical Medical Laboratory	$404.9K	$33.1K
Vamsi Kanagala	GA	Internal Medicine Physician	$409.4K	$0
Jesus Vazquez-figueroa	GA	Internal Medicine Physician	$123.7K	$198K
Shonda Pertilla	GA	Professional Counselor	$0	$155.4K
Ipsum Diagnostics LLC	GA	Clinical Medical Laboratory	$7.6K	$116.6K
Steven Figiel	GA	Neurology Physician	$118.6K	$0
The Kroger Co	GA	Community/Retail Pharmacy	$99.3K	$0

Hemophilia Of Georgia — Billing Profile & Reimbursement Data

Sign up for Hemophilia Of Georgia — Billing Profile & Reimbursement Data policy alerts

Hemophilia Of Georgia — Billing Profile & Reimbursement Data

Sign up for Hemophilia Of Georgia — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References